Director dealings: TUI, Oxford Biomedica board members linked to buys
TUI was among those on the list of director buys on Wednesday after its chief executive officer purchased almost 50,000 shares.
The travel giant said Sebastian Ebel picked up 49,900 shares on 26 September in a single transaction outside a trading venue.
Ebel paid €4.99 for each share, valuing the transaction at a total of €224,325.21 (£194,816.35).
Elsewhere, Oxford Biomedica disclosed a purchase linked to one of its non-executive directors.
The company said Sandra Juliet Ferera Hayden bought 12,000 shares on 26 September in a single transaction on the London Stock Exchange.
Hayden paid 293.5p for each share, valuing the purchase at £35,220.00.
In its disclosure, Oxford Biomedica said Sandra Hayden is a person closely associated with non-executive director Michael Hayden.
At 1304 BST, shares in TUI were up 3.39% in London at 451.6p, while those in Oxford Biomedica were 1.72% weaker at 286.5p.
Reporting by Josh White for Sharecast.com.